IN-VITRO SELECTION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 RESISTANT TO RO 31-8959 PROTEINASE-INHIBITOR

被引：33

作者：

DIANZANI, F ^{[1
]}

ANTONELLI, G ^{[1
]}

TURRIZIANI, O ^{[1
]}

RIVA, E ^{[1
]}

DONG, G ^{[1
]}

BELLAROSA, D ^{[1
]}

机构：

[1] UNIV PISA,DEPT BIOMED,I-56100 PISA,ITALY

来源：

ANTIVIRAL CHEMISTRY & CHEMOTHERAPY | 1993年 / 4卷 / 06期

关键词：

D O I：

10.1177/095632029300400604

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

Human immunodeficiency virus type I (HIV-1) resistant to the proteinase inhibitor Ro 31-8959 has been obtained by growing HIV-IIIB in C8166 cell cultures in the presence of inhibitory concentrations of the drug. Ro 31-8959-resistant HIV-1 obtained after five passages in the presence of the drug was capable of replicating, as measured by infectious virus yield, in the presence of concentrations of Ro 31-8959 able to inhibit completely the replication of the parental HIV-IIIB. Cloning of the Ro 31-8959-resistant viral preparations revealed that a number of different strains of HIV-1 with various degrees of sensitivity to Ro 31-8959 emerged during propagation of HIV-IIIB in C8166 cells in the presence of the drug. The most resistant strain shows an ID50 value of 21.8 nm that is 13.2 fold higher than the value observed in HIV-IIIB infected C8166 cells.

引用

收藏

页码：329 / 333

页数：5

相关论文

共 22 条

[1] ZIDOVUDINE SENSITIVITY OF HUMAN IMMUNODEFICIENCY VIRUSES FROM HIGH-RISK, SYMPTOM-FREE INDIVIDUALS DURING THERAPY [J].

BOUCHER, CAB ;

TERSMETTE, M ;

LANGE, JMA ;

KELLAM, P ;

DEGOEDE, REY ;

MULDER, JW ;

DARBY, G ;

GOUDSMIT, J ;

LARDER, BA .

LANCET, 1990, 336 (8715) :585-590

[2]

CLAIR MHS, 1991, SCIENCE, V253, P1557

[3] HUMAN IMMUNODEFICIENCY VIRUS-INFECTION OF MONOCYTIC AND T-LYMPHOCYTIC CELLS - RECEPTOR MODULATION AND DIFFERENTIATION INDUCED BY PHORBOL ESTER [J].

CLAPHAM, PR ;

WEISS, RA ;

DALGLEISH, AG ;

EXLEY, M ;

WHITBY, D ;

HOGG, N .

VIROLOGY, 1987, 158 (01) :44-51

[4] NEW ACQUISITIONS IN THE DEVELOPMENT OF ANTI-HIV AGENTS [J].

DECLERCQ, E .

ANTIVIRAL RESEARCH, 1989, 12 (01) :1-19

[5] RAPID COLORIMETRIC ASSAY FOR CELL-GROWTH AND SURVIVAL - MODIFICATIONS TO THE TETRAZOLIUM DYE PROCEDURE GIVING IMPROVED SENSITIVITY AND RELIABILITY [J].

DENIZOT, F ;

LANG, R .

JOURNAL OF IMMUNOLOGICAL METHODS, 1986, 89 (02) :271-277

[6] REPLICATION OF HUMAN IMMUNODEFICIENCY VIRUS - YIELD OF INFECTIOUS VIRUS UNDER SINGLE GROWTH-CYCLE CONDITIONS [J].

DIANZANI, F ;

ANTONELLI, G ;

CAPOBIANCHI, MR ;

DEMARCO, F .

ARCHIVES OF VIROLOGY, 1988, 103 (1-2) :127-131

[7] INVITRO SELECTION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 RESISTANT TO 3'-AZIDO-3'-DEOXYTHYMIDINE [J].

DIANZANI, F ;

ANTONELLI, G ;

TURRIZIANI, O ;

DONG, GM ;

CAPOBIANCHI, MR ;

RIVA, E .

ANTIVIRAL RESEARCH, 1992, 18 (01) :39-52

[8] SUSCEPTIBILITY OF HUMAN IMMUNODEFICIENCY VIRUS TO ANTIVIRAL AGENTS MEASURED BY INFECTIOUS VIRUS YIELD REDUCTION [J].

DIANZANI, F ;

CAPOBIANCHI, MR ;

ANTONELLI, G ;

AMICUCCI, P ;

DEMARCO, F .

ANTIVIRAL RESEARCH, 1989, 11 (5-6) :299-305

[9] INHIBITION OF HUMAN IMMUNODEFICIENCY VIRUS-1 PROTEASE INVITRO - RATIONAL DESIGN OF SUBSTRATE-ANALOG INHIBITORS [J].

DREYER, GB ;

METCALF, BW ;

TOMASZEK, TA ;

CARR, TJ ;

CHANDLER, AC ;

HYLAND, L ;

FAKHOURY, SA ;

MAGAARD, VW ;

MOORE, ML ;

STRICKLER, JE ;

DEBOUCK, C ;

MEEK, TD .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1989, 86 (24) :9752-9756

[10] SELECTIVE PHOSPHINATE TRANSITION-STATE ANALOG INHIBITORS OF THE PROTEASE OF HUMAN-IMMUNODEFICIENCY-VIRUS [J].

GROBELNY, D ;

WONDRAK, EM ;

GALARDY, RE ;

OROSZLAN, S .

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1990, 169 (03) :1111-1116